Immunogen Inc Net Income per Employee (IMGN), current and historic results, rankings and more, Quarterly Fundamentals - CSIMarket
CSIMarket
 


Immunogen inc   (NASDAQ: IMGN)
 

Immunogen Inc Net Income per Employee

IMGN's Quarterly Results, Trends, Rankings, Statistics
Immunogen Inc recorded a cumulative net loss of $-74 million during 12 month ending in the third quarter 2023.
The Healthcare sector has seen employees of 121 other companies achieving higher income per employee. While Immunogen Inc 's total ranking has deteriorated compared to the previous quarter from 2823 to 3223.


What is Income per Employee Ratio?






IMGN Net Income per Employee (Sep 30 2023)
III. Quarter
(Jun 30 2023)
II. Quarter
(Mar 31 2023)
I. Quarter
(Dec 31 2022)
IV. Quarter
(Sep 30 2022)
III. Quarter
Y / Y Net Income Change - - - - -
Net Income per Employee (TTM) $ -212,491 -526,084 -693,058 -644,303 -581,194
IMGN's Total Ranking # 3223 # 2823 # 2535 # 1982 # 0
Seq. Net Income Change - - - - -


IMGN Net Income per Employee Company Ranking
Within: No.
Major Pharmaceutical Preparations Industry # 122
Healthcare Sector # 361
Overall Market # 3223

Net Income per Employee Statistics
High Average Low
$ -164,058 $ -370,372 $ -693,058
(March 31, 2015)   (Mar 31 2023)







Companies with similar Income per Employee for 12 month ending Sep 30 2023, within Healthcare Sector Income per Employee Income 12 month ending Sep 30 2023Number of Employees Sep 30 2023


Date modified: 2026-08-29T17:15:19+00:00




Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.

© 2026 CSIMarket.com — Proprietary financial dataset. All rights reserved. Redistribution or automated extraction prohibited.